Blog
Keep up to date with the latest news from Instem.
Instem Unveils New Global Headquarters in Boston, MA
A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem
Unifying Acquisitions Under One Instem Brand
A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee
Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Instem Announces Acquisition of RockStep Solutions, Inc.
Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration
Instem Moves into New Sustainable, Client-Centric Office at Smartworks 43EQ, Pune, India
Instem is pleased to announce the opening of our new office in Balewadi, Pune, India.
Instem and VICT3R: Pioneering Ethical Innovation in Toxicology Studies
Instem is a contributing partner in the VICT3R Consortium, a collaborative initiative exploring the use of Virtual Control Groups (VCGs) in toxicology studies.
Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions
Strong Tower Solutions is now a part of Instem
Instem at SOT 2025: A Resounding Success in Advancing In Silico Toxicology
The Society of Toxicology (SOT) 2025 Annual Meeting was an incredible experience for Instem, with packed sessions, insightful discussions, and exciting new connections.
Shaping the Future of Computational Toxicology – Instem’s SOT 2025 Sessions
Join Our Experts at SOT 2025 for Scientific Insights and Networking.
Orange County Convention Center | Booth #1033
